Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD Clinical research trials and Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD. Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD clinical trial. Human subjects often receive the most effective healthcare possible for their Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "D" Clinical Trials Conditions > Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD

Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD



Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD

For Condition: Acute Graft Versus Host Disease
Status: Recruiting
Sponsor(s): SuperGen ,
Synopsis: To determine a safe and effective dose of pentostatin in steroid-refractory aGvHD and to identify the minimal effective dose of pentostatin defined as the lowest dose that produces a response in 20% or more of patients while producing treatment failure (defines as death, grade 3/4 toxicity, or progressive disease) in 40% or less of patients.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Non-Randomized, Open Label, Dose Comparison, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 6 Months/
Genders: Both
Protocol Entry Criteria: Inclusion: - Patients 6 months of age with grade 2 GVHD that is steroid-refractory - Must be engrafted with ANC 1000/mL, may still be transfusion dependent for platelets and PRBC - Time post stem cell infusion < 100 days - Written informed consent - Must have adequate renal function (creatinine clearance 40 mL/min/1.73 m2 Exclusion: - Post-transplant lymphoproliferative disease - Uncontrolled infection - Mental illness or other condition preventing full cooperation with the treatment and monitoring requirements of the study - ATG within the previous 14 days - Other immunosuppressive agents (including monoclonal antibodies) when initiated within the previous 7 days.
Total Enrollment: 36

Location and Contact Information:

MD Anderson Cancer Center *Recruiting*
Houston,  Texas, 
United States
Recruiting  


Additional Information:
Study ID Numbers:
  SGI-NIP-010;  NIP-010
Study Start Date: 
Record last reviewed: April 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00032773

Other Acute Graft Versus Host Disease Studies:
1. Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD

2. Phase I/II trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

Related Studies:

Other Acute Graft Versus Host Disease Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials

Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD

Modify your Search

  Other Acute Graft Versus Host Disease Clinical Trials
  Other Texas Clinical Trials
  Other Houston Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103